Orchid Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

50.72

40.82

40.82

40.82

40.82

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

1,167.60

691.15

637.14

640.52

1,015.38

Loan funds

Secured loans

134.26

331.35

267.95

430.34

501.47

Unsecured loans

-

-

-

-

-

Total

1,352.57

1,063.31

945.91

1,111.68

1,557.67

Uses of funds

Fixed assets

Gross block

1,285.18

1,210.07

1,165.92

1,165.67

1,419.94

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

668.75

637.01

582.27

495.28

381.13

Net block

616.43

573.06

583.65

670.39

1,038.81

Capital work-in-progress

24.46

46.09

9.78

7.43

88.52

Investments

69.40

50.12

49.01

15.43

0.34

Net current assets

Current assets, loans & advances

841.91

553.99

451.74

531.23

584.07

Less : current liabilities & provisions

199.63

159.95

148.28

112.79

154.07

Total net current assets

642.28

394.04

303.46

418.43

430.00

Miscellaneous expenses not written

-

-

-

-

-

Total

1,352.57

1,063.31

945.91

1,111.68

1,557.67

Notes:

Book value of unquoted investments

69.15

174.68

173.69

125.04

125.04

Market value of quoted investments

0.25

0.14

0.09

0.13

0.06

Contingent liabilities

59.23

44.91

24.87

45.31

0.97

Number of equity sharesoutstanding (Lacs)

507.19

408.16

408.16

408.16

408.16